rs104894681
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_024301.5(FKRP):c.1343C>T(p.Pro448Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000187 in 1,601,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P448P) has been classified as Likely benign.
Frequency
Consequence
NM_024301.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FKRP | NM_024301.5 | c.1343C>T | p.Pro448Leu | missense_variant | 4/4 | ENST00000318584.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FKRP | ENST00000318584.10 | c.1343C>T | p.Pro448Leu | missense_variant | 4/4 | 1 | NM_024301.5 | P1 | |
FKRP | ENST00000391909.7 | c.1343C>T | p.Pro448Leu | missense_variant | 4/4 | 2 | P1 | ||
FKRP | ENST00000597339.5 | n.247-5040C>T | intron_variant, non_coding_transcript_variant | 5 | |||||
FKRP | ENST00000600646.5 | n.247+8128C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000897 AC: 2AN: 222986Hom.: 0 AF XY: 0.00000825 AC XY: 1AN XY: 121274
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1448714Hom.: 0 Cov.: 32 AF XY: 0.00000139 AC XY: 1AN XY: 719810
GnomAD4 genome ? AF: 0.00000657 AC: 1AN: 152320Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74486
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | FKRP: PM3:Strong, PM2, PS3:Moderate, PP3, PP4 - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 14, 2017 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2I;C1847759:Muscular dystrophy-dystroglycanopathy type B5;C3150413:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;C4284790:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 28, 2022 | - - |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 08, 2023 | - - |
Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 5 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2001 | - - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2022 | The p.P448L variant (also known as c.1343C>T), located in coding exon 1 of the FKRP gene, results from a C to T substitution at nucleotide position 1343. The proline at codon 448 is replaced by leucine, an amino acid with similar properties. This alteration has been reported as homozygous in an individual with congenital muscular dystrophy (Brockington M et al. Am J Hum Genet, 2001 Dec;69:1198-209). Additionally, both in vitro and in vivo assays showed this alteration impacts protein function, including a homozygous knock-in mouse that showed this alteration almost completely lacks functional glycosylation of alpha-dystroglycan in muscles and brain (Esapa CT et al. Hum Mol Genet, 2002 Dec;11:3319-31; Esapa CT et al. Hum Mol Genet, 2005 Jan;14:295-305; Keramaris-Vrantsis E et al. Muscle Nerve, 2007 Oct;36:455-65; Lu PJ et al. Biochim Biophys Acta, 2010 Feb;1802:253-8; Chan YM et al. Hum Mol Genet, 2010 Oct;19:3995-4006; Maricelli JW et al. PLoS One, 2016 Sep;11:e0161984; Blaeser A et al. PLoS One, 2016 Oct;11:e0164187). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Walker-Warburg congenital muscular dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | May 08, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects FKRP function (PMID: 12471058, 15574464, 19900540, 20675713, 27711214, 29858056, 30417025). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FKRP protein function. ClinVar contains an entry for this variant (Variation ID: 4220). This missense change has been observed in individuals with muscular dystrophy (PMID: 11592034, 31069529). This variant is present in population databases (rs104894681, gnomAD 0.007%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 448 of the FKRP protein (p.Pro448Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at